id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-4058-0001,FDA,FDA-2024-N-4058,Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Clozapine Test System,Rule,Final Rule,2024-09-16T04:00:00Z,2024,9,,,2024-09-16T14:51:24Z,2024-20895,0,0,0900006486722dad